Abstract
Glioblastoma is the most common and malignant adult brain tumor. Standard treatment consists of temozolomide (TMZ), surgery and radiotherapy (RT) (1). However, despite multimodal treatment, the average survival of patients with glioma is between 9–12 months after initial diagnosis, and tumor recurrence is almost 100% (2). The main characteristics of glioma are: high rates of cell proliferation; highly invasive and infiltrative across the surrounding vessels, myelinated fibres and areas of necrosis and highly angiogenenic. Glioblastoma is composed by heterogeneity cells; some cells have a genetic and cellular heterogeneity characteristic in human tumor. It is important to identify these subpopulations of tumor cells with stem-cell like characteristics (3) because these cells are related with treatment resistant and glioma recurrence (4). Understanding these cells characteristics and their metabolism are important to design new treatments against glioma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
